Shares of Terumo Corp. (OTCMKTS:TRUMY – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $14.68, but opened at $13.68. Terumo shares last traded at $13.68, with a volume of 234 shares traded.
Wall Street Analyst Weigh In
Separately, Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Buy”.
Check Out Our Latest Research Report on Terumo
Terumo Stock Performance
Terumo (OTCMKTS:TRUMY – Get Free Report) last posted its earnings results on Friday, August 7th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.17 by $0.13. Terumo had a net margin of 13.83% and a return on equity of 10.44%. The company had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.84 billion. As a group, research analysts expect that Terumo Corp. will post 0.7 EPS for the current year.
Terumo Company Profile
Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.
Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions.
Recommended Stories
- Five stocks we like better than Terumo
- 3 Retail Stocks Getting Crushed and the Long-Dated Options Trade on Each One
- 3 Overlooked Tech Names Quietly Powering Everyday Life
- 5 Dividend Stocks That Combine Income, Earnings Growth, and Wall Street Support
- These 3 AI Stocks Sold Off Hard—Even as Their Outlooks Improved
Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.
